Toyo Taiwan is one of Taiwan's leading pharmaceutical companies dedicated to the research and development of anti-infective drugs for cancer and critical illnesses. In addition to the development, manufacturing, and international marketing of specialty drugs, biologics, and new medicines, TOYO expects to be the world's most innovative health care policy regulator, and wants to provide patients with new and natural gastric medication choices. TOYO has further developed its self-funded medication, Alginos Gastric Reversal, and will partner with Process Pro Brands in 2019 to carry out a branding program.